Two oxytocin analogues were synthesized by fragment condensation (6 -]-3) in the presence of dicyclohexylcarbodiimide and I-hydroxybenzotriazole. In one of the analogues, proline in the position 7 and leucine in the position 8 were substituted by 2MI!-(2-oxo-3-aminopyrrolidinyl)]--q-methylpentanoic acid, in the other proline was replaced by l-aminocyclopropane-I-carboxylic acid. Biological activities of the first analogue were strongly reduced and dissociation of the uterotonic and galactogogic activities was observed with both the analogues. The structure of 2-(3-tert~butyIoxycarbony laminopyrrclidin-Zeon-l-ylj-a-methy lpentanoy lglycine and its amide was confirmed by mass and 1 H NMR spectroscopy.
The number of known oxytocin analogues modified in the sequence position 7 is surprisingly small, particularly if one considers their biological activity. The position 7 should be of importance not only for bonding to the corresponding receptor bnt also (as a corner amino acid of the assnmed p-turn) for keeping tbe correct spatial arrangement.'. Also the importance of enzymic cleavage of the tripeptide side chain cannot be neglected/:". An enhanced uterotonic activity has been observed with analogues containing dehydroproline" or thiazolidinecarboxylic acid,·6 which cannot substantially change the spatial orientation of the terminal tripeptide; on the other hand, their higher Iipophilicity could improve the hydrophilic interaction with the receptor. Analogues, modified by introduction of glycine?"?", which is also a suitable amino acid for the p-turn corner position, show a strong dependence of activity on magnesium content in the tested medium, their activity in the presence of magnesium reaching values up to twice higher than that of oxytocin (965 I.U./mg).
Introduction of D-proline
ll leads to a substantial decrease in activity, but a far larger decrease is caused by introduction of n-leucine", Reduction in size of the proline ring 12 results in about tenfold reduction of the activity; replacement of one of the hydrogens in the proline ring by hydroxyl'P'!" is accompanied by a complete loss of activity showing again the importance of Iipophilicity of the amino acid in the position 7. Alanine in this position" rednces the activity whereas methylation of its nitrogen atom (N-methylalanine) increases the activity!", in the case of sarcosine!5 even to the oxytocin level.
One of the modifications which we effected in position 7 was the so-called proline shift. The ring in the side chain is not closed by bond to the nitrogen atom of the amino acid in position 7 (as in the case of proline) but to nitrogen of the amino acid in the position 8 (i.e. to the leucine uitrogen). The riug size is thus the same but the cyclic rigid structure is shifted towards the carboxyl end of the molecule. Such a modification was studied by the American authors'" and applied to the analogues of LHRH17 and enkephalin" where it fixed the secondary structure. In our second analogue, proline in the position 7 is replaced by l-aminocyclopropane-l-carboxylic acid. A part of our resnlts has been published as a preliminary communication!", Both the analogues* were prepared using the 6 + 3 fragment condensation.
Boc-NH ·CH-CQ-N-CH-"CO-
In the synthesis of the analogue VIIa, the corresponding tripeptide was prepared by treatment oLtert-butyloxycarbonylmethionyl-leucyl-glycine etbyl ester 21 (1) with methyl iodide togive the sulfonium salt II, whichreacted with sodium hydride to close the five-membeJ;~d ring under simultaneous hydrolysis of the ester group. The resulting derivative Hlc was esterified with diazomethane to give the ester Illb which 011 ammonolysis;afforded the amide Illc.
The structure[of the tripeptide lIla was proved by 'H NMR and mass spectroscopy. For the interpretation of the NMR spectrum see Fig. 1 , from the other end of this ion results in the dominant ion mlz 213, which eliminates H~orOO2~~~~1~~1~~~~98~~~in=~s plitting (Fig. 2) . Alternatively, the fragmentation of M+ proceeds with preservation of its carboxylic (or carboxamidic) end, resulting in formation of characteristic ions which differ by one mass unit for the corresponding processes in the mass spectra of lIla and Lllc, Thus, the consecutive elimination of the alkyls C. The carboxy-terminal tripeptide amides LlIc and IVb were deprotected with trifluoroacetic acid and hydrogen bromide, respectively, and condensed with N-benzyloxycarbonyI-S-benzyIcysteiny1-tyrosyl-isoleucy1-glutaminyl-asparagiuyl-S-benzylcysteiue obtained from the corresponding fully protected hexapeptide V (re [23) by treatment with trifluoroacetic acid. The condensation was performed with an excess ofdicyclohexylcarbodiimide and Lhydroxybenzotriazole and the product was purified by chromatography on a column of Sephadex LH-20 in dimethylformamide. The protecting groups in the nonapeptide VI a were removed with sodium in liquid ammonia whereas the nonapeptide VI b was treated with anhydrous liquid hydrogen fluoride in the presence of anisole because sodium in liquid ammonia opened the three-membered ring in the l-aminocyclopropanecarboxylic acid moiety (cf. the hydrogenolytic ring opening/"]. The sulfhydryl groups were oxidized with potassium ferricyanide and after de-salting both analogues were purified by reversed phase high performance liquid chromatography.
Both analogues have lower biological activities than oxytocin, with dissociation of the uterotonic and galactogogic activities.
This dissociation in favour of the galactogogic activity has been found for all hitherto described oxytocin analogues, modified only in position 7 (considering analogues with only one structural modification), except analogues with a n-arnino acid in the position 7, where the uterotonic aetivity is favoured. The most apparent dissociation in favour of galactogogic activity has been observed for the analogues, containing azetidinecarboxylic acid, l-aminocyclopropane-Lcarboxylic acid, or N-methylalanine as the modifying elements, common feature of the first two being a significant deformation of the N-C'-C' bond angle.
Oxytocin analogues, modified only in the position 7, can be classified into two groups according to their uterotonic activity: analogues which are more active than tocinamide 2 5 • 2 6 and those with lower activity. In the latter analogues, the spatial arrangement of the cyclic part is for various reasons also affected, which in tocinamide is ont of the qnestion. The very low activities of the analogue VIla indicate that such a substantial change in structure of the terminal tripeptide evidently perturbs the spatial arrangement of the whole peptide and thus affects unfavonrably its interaction with the receptor.
EXPERIMENTAL
Melting points were determined on a Kofler block and are uncorrected. Analytical samples were dried at~oom temperature and 150 Pa for 24 h. Thin-layer chromatography (TLC) was carried out on silica gel coated plates (Silufol, Kavalier, Czechoslovakia) in the following systems: 2-butanol-98% formic acid-water (75: 13·5: 13,5) (SI), 2-butanol-25% ammonia-water (85: 7·5 : 7,5) (S2), l-butnnol-acetic acid-water (4: I : 1) (53), I-butanol-acetic acid-water--pyridine (IS : 3 : 6: 10) (54). Paper electrophoresis was performed in a moist chamber in 1M acetic acid (pH 2-4) and in pyridine-acetate buffer (pH 5'7) on Whatman 3MM paper at20 V/cm for 60 min. Spots inTLCand electrophoresis were detected with ninhydrin or by chlorination method. The reactipn mixtures were concentrated on a rotatory evaporator at bath temperatures 30-40°C invac~J.1I11ofawater pump (mixtures containing dimethylformamide at 150 Pa). Samples for arningacidanalysis were hydrolyzed with 6M~HCI at 1OSoe for 20 h and analyzed On an automatictw~-column instrument (type 6020,Developmental Workshops of Czechoslovak Academy ofScicllycs) or on a D-500 analyzer (Durrum Corp.), Optical rotations were determined On a Perkin_Elmerinstrurnent type 141 MeA (Norwalk, USA). High performance liquid chromatography«I-IPIfC) was carried out On an SP-8700instrument equipped with an SP-8400 detectorandSP7"4;100 integrator (all from Spectra Physics, Santa Clara, USA), using a Separon SI-C~18 (25 X 0'4'cm) column (Laboratorni Pfistroje, Prague).
IH NMRspectrum of IlIa was taken On a Varian XL-200 spectrometer (at 200 Ml-lzj in deuteriochloroform-hexadeuteriodimethyl sulfoxide (2: 1) with tetramethylsilane as internal standard at 23°C Electron impact induced mass spectra were measured on a double focussing mass spectrometer AEI MS902 (Associated Electric Industries, Manchester). 70 cV, direct inlet at about IS0°C, resolving power 1 000. High resolution measurements were performed at resolving power 10 000 and the exact masses found for the elemental compositions were within ±2 mmu of the theoretical value.
2-(3-Tert-buty loxycarbony laminopyrrolidin-Zron-l-y Ij-q-methylpentancyl-glycine (IlIa) Methyl iodide (1 ml) was added to the tripeptide [(ref.21; 1 g) in methanol (30 ml) and the format on of the sulfonium salt was monitored by reversed phase HPLC After disappearance of the starting compound I (24 h) the mixture was taken down and the residue dried in vacuo. The remaining product II was dissolved in dimethylformamidc (4-6 ml), sodium hydride (164 mg) was added and the mixture was stirred for 10 min at room temperature. After decomposition with water (100 ml) the resulting solution was stirred for 20 min, acidified with solid sodium hydrogen sulfate to pH 3 and extracted with ethyl acetate, The organic layer was washed with water, dried over sodium sulfate and taken down, affording 0-76 g (91%) of the product, melting at 163-170°C. An analytical sample was crystallized.from aqueous methanol, m.p. 168-171°C.
For C17H29N306.1!Z H 20 (380'4) calculated: 53-67% C, 7-95% H, 11-04% N; found: 53-39% C. 8 '01% H, 10-77% N. According to the amino acid analysis, the product did not contain leucine or methionine but an amino acid was present which was eluted 6 min before methionine.. .°3), 298 (3'7, CI3H20N305)' 315 (5'3, C'3H2,N306), M+ 371 (I).
2-(3-Tert-butyl oxycarbonylaminopyrrolidin-Z-on-1-yI)~4-methylpentanoyl-gl ycine Amide

(IIle)
The compound IlIa (0,54 g) in methanol (20 ml) was treated with an ethereal solution of diazomethane. After standing for S min the excess diazo methane was destroyed with acetic acid (30 ul) and the solventwas evaporated, leaving IlIb, pure according to TLC (R F 0-64 in 52) and HPLC (k' 14'3; for the starting acid: k' 3-27) in methanol-O'Ddra ammonium acetate pH 7, 1 : 1. The product IlIb was dissolved in a methanoIic solution of ammonia (60 ml) and the ammonolysis was followed by HPLC in the above-mentioned system (k' 5-68). After 24 h the mixture was taken down and the product dried in vael/O, affording 0-52 g (98%) of IlIe, rn.p. 
Stability of IIIe towards Sodium in Liquid Ammonia
Sodium was added to a solution of IIIc (10 mg) in liquid ammonia (15 ml) until the blue colouration persisted for 90 s. After decomposition with acetic acid the mixture was freeze-dried. The residue was dissolved in water and the product extracted with ethyl acetate. The extract "vas dried over sodium sulfate and taken down, leaving S'3 mg of a residue, shown by HPLC to be the unchanged starting material.
BenzyloxycarbonyI-l-aminocyclopropane-l-carboxy-Ieucyl-glycine Ethy 1 Ester (l Va)
Benzyloxycarbonylleucyl-glycine ethyl ester (350 mg) was dccarbobcnzoxylated in 35% HBr in acetic acid (1 ml), the mixture was diluted with ether and the separated dipeptide hydrobromide was triturated several times with fresh ether and dissolved in chloroform (2 ml). The solution was adjusted to pH 7-S and benzyloxycarbonyl-l-aminocyclopropane-1-carboxylic acid 2 2 (235 mg) was added, followed, after cooling to -WoC, by dicyclohexylcarbodiimide (230 mg).
The mixture was stirred at -lOoe for 1 h and at ooe overnight. The separated dicyclohexylurea was filtered off, the filtrate was taken down and the residue dissolved in ethyl acetate. After washing with 1M-HCI, water, 0·5M-NaI-IC0 3 and water, the solution was dried over sodium sulfate and taken down. The residue was reprecipitated from ether-light petroleum and the remaining oil crystallized on keeping in a refrigerator overnight. The crystals were filtered and dried, affording 350 rug (77%) of a hygroscopic product; R F 0·83 (51), 0·68 (52), 0·80 (54), HPLC: le' 2'62 (methanol-OvlS; trifluoroacetic acid 75: 25). [0:1 0 -22'7°(c 0·2; methanol). For C 12H 31N300 (433'5) calculated: 60'95% C, 7·21% l-I, 9'69% N; found: 60·51% C, 7'35% l-I, 9'91% N.
BenzyloxycarbOnyl-1-aminocyclopropane-l-carboxy-leucyl-glycine Amide (IVb)
A solution of the compound IVa (320 mg) in methanol (10 ml) was mixed with 50% mcthanolic ammonia (10 ml). After standing for 4 days in a stoppered flask at room temperature, the mixture was taken down and the remaining foam was dissolved in methanol-water (45 : 55; 8 ml) and purified by HPLC in methanol-water (55: 45) On Partisil ODS. Yield 180 rng (61%) of amorphous product, pure according to HPLC tk' 3'94; methanol-water 60: 40); [0:]0 -33-2" (cO'3; methanol). R F 0·66 (51); 0·56 (52); 0'67 (53); 0·75 (54). Amino acid analysis: Gly 1'04, Leu 1'00, Ace 0·S6. For C201-12sN40s.0·5 H 20 (413'5) calculated: 5S·13% C. 7'07% H, 13'55~~N; found: 58'45%,c, 7'08% H, 13'43% N.
NO:~BenzyIoxycarbony1-5-benzyl cysteinyI-tyrosy1-Isoleucyl-glutamin yl-a 5paraginy1--SebenzylcysteinyI~[2-(3-aminopyrrolidin-z-on-f-y lj-q-rnethylpentanoyljglycine Amide (VIa)
A solution of the protected hexapeptide V (ref. 23 ; 100 mg) and compound IlIe (96 rng) in trifluoroacetic acid (2 ml) was set aside for 1 h at room temperature. The mixture was twice coeva-porated with toluene (2ml). the residue dissolved in dimethylformamide (2 ml) and the solution adjusted with N-ethylpiperidine to pH 8 (moist pH indicator paper). After addition of N'hydroxybenzotriazole (35 mg) and cooling to -lOoe, dicyclohexylcarbodiimide (85 mg) was added. The mixture was stirred for 1 h at -lOoe and for 40 11 at room temperature, filtered, concentrated, applied On BanzyIoxyca rb30yI-S-benzy Icysteiny1-ty rosy1-isoIeucyl-gl utaminyl-asparaginy1--S-benzylcysteinyl-l-aminocyclopropane-l-carboxy-leucyJ-glycine Amid e (Vlb) A solution of the tripeptide IVb (81 mg) in acetic acid (0-2 ml) was mixed with 35% HEr in acetic acid (0'3 011). After standing at room temperature for 30 min the mixture was diluted with ether. The separated tripeptide hydrobromide was isolated by decanting the supernatant, dissolved in dimethylformamide (l 011) and the solution was adjusted to pH 8 with Neethylpiperidine. NrBenzy1oxycarbony I-SebenzyIcysteinyl-Oetert-b utyItyrosyIRisoleucy I-gIutaminy 1-aspara ginyl-S-benzyIcysteine tert-butyl ester (V; ref. Z3; II7 mg) was dissolved in trifluoroacetic acid (2 ml) and set aside for 1 h at room temperature. After addition of toluene (2 ml) the solution was taken down, the residue was dissolved in dimethylformamide (1 ml) and mixed with solution of the tripeptide amide, prepared as described above. The solution was adjusted to pH 7-8 with Neethylpiperidinc, and Iehydroxybenzotriazole (40 mg) was added. After cooling to -20°C dicyclohcxylcarbcdiirnidc (100 mg) was added and the mixture was stirred at _WoC for 1 h, at DoC for 1 h and at rocm temperature overnight. The separated dicyclchexylurca was filtered, the filtrate concentrated to 1·5 ml and applied on a column of Sephadex LH-20 (1 X 200 em). Elution with dimethylformamide was monitored by differential refractometer. Fractions 61-68 ml after evaporation afforded 68 mg (52%) of the product. R F 0·78 (S4). The protected peptide VIa (60 mg) was dissolved in liquid ammonia (20 ml) and reduced with sodium, The blue cclouration, persisting for 40 s, was destroyed with acetic acid and the solution was lyophilized. The residue was dissolved in 0'1M-HCI (10 ml), diluted with water to 100 ml and adjusted to pH 7 with O·IMRNaOH. A solution of K 3Fe(CN)6 (35 mg in 7 ml of water) Wasadded during 1 h, the mixture was acidified with acetic acid to pH 4 and applied On a column of Amberlite IRe-50 (15 ml). After washing with 0'25% acetic acid the product was eluted with 50% acetic acid, the eluate was concentrated and freeze-dried. The residue was dissolved in methanol-water (3 : 7; 8 ml) and applied on a column of Partisil ODS (50 X 0'9 em). Elution with methanol-D'05% triftuoroacetic acid (9: 11) and lyophilization of the corresponding fractions afforded 9 mg (21%) of the product. R F 0·17 (SI), 0'10 (S2), 0·09 (S3), 0·58 (S4 14-81% N.
[a]n -24'4°(c 0:11; 31' .1 acetic acid). Amino acid analysis. Asp 1'03, Glu 1'07, Glyl-Ill , Cys 1-91, Ile 0,99, Tyr 0-98, an amino acid, eluted 6 min before methionine 0-97 (related to the constant of leucine). A compound which did not contain the carboxy~terminal tripeptide was obtained as a side product (12 mg; 28%).
Stability of l-Aminocyclopropane-l-carboxylic Acid towards Sodium in Liquid Ammonia and Anhydrous Liquid Hydrogen Fluoride Sodium was added to a solution of Ivaminocyclopropane-I-carboxylic acid (ref.22; 2 mg) in liquid ammonia till the blue colouration persisted for 5 min. The excess sodium was destroyed by addition of ammonium chloride and lyophilized. Composition of the lyophilizate was followed by amino acid analysis. In addition to the starting amino acid, a large amount of a compound was found, whose elution time corresponded to that of c-aminobutyric acid or cc-aminoisobutyric acid.
A solution of l-aminocyclopropane-l-carboxylic acid (2 rng) and anisole (0'1 ml) in anhydrous liquid hydrogen fluoride (5 ml) was kept at 20 0 e for 1 h and evaporated. Amino acid analysis of the residue found only the starting acid.
[7-( 1-Aminocycl opropanecarboxyfic acidjjoxytocin (VIIb)
The protected nonapeptide Vlb (65 mg) was reduced at 20 0 e for 1 h with liquid hydrogen fluoride in the presence of anisole (0'5 ml) in an apparatus for work with liquid hydrogen fluoride (Toho Kasei Co., Osaka, Japan). After evaporation of hydrogen fluoride the residue was disolved in acetic acid (2 ml), diluted with water (20 ml) and lyophilized. The lyophilizate was dissolved in water (70 ml), the solution adjusted to pH 3 with O'IM-HCI and extracted several times with ether. The aqueous layer was degassed, adjusted to pH 7·0 with O'IM~NaOH and potassium ferricyanide (33 rng) in water (7 ml) was added during 5 min. The pH was kept for 30 min at 7'0 by addition of O'IM-NaOH and then adjusted to 4 with acetic acid. The solution was applied on a column of Ambcrl ite CG-50! (free acid; 5 ml). After washing with 0'25% acetic acid, the product was eluted with 50% acetic acid. The eluates (30 ml) were freeze-dried, the residue was dissolved in methanol-O'LX trifluoroacetic acid (33 : 67; 12 ml) and applied on a column of Partisil ODS (50 x 0·9 ern). Elution with methanol-Ovl X trifluoroacetic acid (40: 60) afforded 1·52 mg of the lyophylizate, representing the product VIIb, pure according to HPLC (k' 3-94; methanol--0'1% trifluoroacetic acid 45: 55). R F 0·26 (51), 0·21 (82). 0·67 (54). E~.'~0'30, E~.IX 0'75;
[a]n -25'3°(cO'l; 1M acetic acid). For C 42H6 4N 12012S2.CF3COOH.3 H 20 (1 161'2) calculated:
45'51% c. 6 '16% H, 14-47% N; found: 45'84% C, 6'32% I-I. 13-98% N. Amino acid analysis: Asp 1'06, Glu 1'07, Gly 1'00, Cys 1·55, IIe -I-Ace 2,09, Leu 0'96, TyrO'90, Cys(Bzl) 0'00.
Pharmacological Methods
The uterotonic activity was determined on an isolated rat uterus according to Holton 27 in the Munsick's modificatione'', the milk-ejecting activity by a modified 30,32 method of Bisset and coworkers-", and th~pressor activity on despinalized rats according to Krejci 31. 
